Global Reach ACM Global Laboratories operates in over 65 countries globally, offering a significant opportunity for international sales expansion and partnerships.

COVID-19 Focus With a strong emphasis on COVID-19 vaccine studies and development, ACM Global Laboratories presents a sales opportunity for companies involved in pandemic-related research and clinical trials.

Therapeutic Services ACM Global Laboratories' launch of therapeutic services for infectious disease testing provides a niche sales opportunity for companies specializing in drug testing and clinical trials.

Strategic Acquisition The strategic acquisition of DRUGSCAN, Inc. showcases ACM Global Laboratories' growth strategy, presenting potential sales opportunities for collaborative ventures or service expansions.

Biotechnology Industry Presence Being part of the biotechnology research industry with a revenue ranging from $100M to 1B, ACM Global Laboratories is well-positioned to engage with similar companies for mutually beneficial partnerships or sales collaborations.